Continuous-flow synthesis of empagliflozin via microchannels: temperature-controlled formation of C-glycosidic bonds at low temperatures, reaction time shortened to the range of seconds to minutes, with purity up to 99%
Empagliflozin synthesis includes C‑glycosidic bond formation, low‑temperature control and stereoselective reduction. Temperature, mixing and residence time govern selectivity and product quality. Continuous-flow microchannel reactors improve heat/mass transfer by microscale effects and allow accurate residence time tuning, offering process intensification for these steps.
Nov 13,2026













